DYNAVAX TECHNOLOGIES CORP Supply Agreements
12 Contracts & Agreements
- Supply Agreement, effective as of September 7, 2023, by and between Company and Nitto Denko Avecia Inc (Filed With SEC on November 2, 2023)
- Amendment No. 3 to Supply Agreement, dated effective as of April 26, 2023, by and between Company and Biological E. Limited (Filed With SEC on August 3, 2023)
- Amendment No. 2 to Supply Agreement, dated effective as of September 30, 2022, by and between the Company and Biological E. Limited (Filed With SEC on November 3, 2022)
- Amendment No. 1 to Supply Agreement, dated effective as of June 23, 2022, by and between the Company and Biological E. Limited (Filed With SEC on November 3, 2022)
- First Amendment to Commercial Manufacturing and Supply Agreement dated September 10, 2021 by and between Baxter Pharmaceutical Solutions LLC and Dynavax Technologies Corporation (Filed With SEC on November 4, 2021)
- Supply Agreement dated July 1, 2021 by and between Company and Biological E. Limited (Filed With SEC on August 4, 2021)
- Supply Agreement dated June 29, 2021 by and among Company, Zhejiang Clover Biopharmaceuticals, Inc., and Clover Biopharmaceuticals (Hong Kong) Co., Limited (Filed With SEC on August 4, 2021)
- Supply Agreement, dated September 11, 2020, by and among the Company, Valneva Scotland Limited and Valneva Austria GmbH (Filed With SEC on November 5, 2020)
- Supply Agreement, dated July 27, 2016, between Company and West Pharmaceutical Services, Inc (Filed With SEC on March 8, 2018)
- Supply Agreement, dated October 1, 2012, between Company and Nitto Denko Avecia, Inc (Filed With SEC on March 8, 2018)
- Supply Agreement, dated November 2, 2016, between Company and Becton, Dickinson and Company (Filed With SEC on March 8, 2018)
- Commercial Manufacturing and Supply Agreement, dated November 22, 2013, between Company and Baxter Pharmaceutical Solutions LLC (Filed With SEC on March 8, 2018)
